Busan National University and Ronpic Collaborate on Digital Health Clinical Validation... Accelerating Commercialization of AI Healthcare Technologies

Clinical Validation of AI Healthcare
Personalized Health Management
Establishing a Hospital-Community Connected Platform

Busan National University is partnering with the advanced AI robotics healthcare company Ronpic (RONFIC) to launch clinical validation of digital healthcare technologies.

Busan National University (President Choi Jaewon) signed a memorandum of understanding with Ronpic on May 22 at the Glocal Clinical Validation Center on the Ami Campus for "clinical research and technology validation based on digital health."

Busan National University is signing a memorandum of understanding for collaboration on digital health clinical validation with Ronpic. Photo by Busan National University

Through this agreement, the two parties will collaborate on the following: clinical validation and advancement of AI robot-based healthcare technologies; development of customized health management models for the elderly and patients with chronic diseases; and establishment of a hospital-community connected platform based on digital therapeutic devices.

As part of this agreement, Ronpic has provided its responsive stepper-based full-body composite exercise device, "CLIMIT," to the Busan National University Glocal Clinical Validation Center. This equipment will be used for clinical validation research in the fields of rehabilitation medicine, geriatrics, and smart health.

Shin Myungjun, Director of the Glocal Clinical Validation Center at Busan National University (Head of the Biomedical Specialization Headquarters), stated, "This agreement is a meaningful starting point for technology commercialization and patient-centered digital transformation," adding, "We aim to present a model in which the region and hospitals jointly lead the digital health ecosystem."

Baek Junyoung, CEO of Ronpic, said, "Through Busan National University's research and clinical capabilities, we are able to secure the reliability and scalability of our technology," and added, "We will continue to develop innovative technologies that contribute to public health."

This agreement was promoted as part of the Biomedical Specialization Headquarters' strategy to revitalize the regional bioindustry and strengthen industry-academic cooperation. Busan National University plans to further expand its network with local bio companies in the future.

This content was produced with the assistance of AI translation services.